Sensitivity and specificity of a whole-blood RNA transcript-based diagnostic test for the diagnosis of prostate cancer (CaP) compared with prostate-specific antigen (PSA) alone.
5052 Background: Screening for CaP with PSA testing is limited by a high number of false postives, particularly in the setting of benign prostatic hypertrophy (BPH). The goal of this study was to develop whole blood RNA transcript-based diagnostic tests that improve the diagnosis of CaP over PSA alo...
| Publicado en: | Journal of Clinical Oncology Vol. 27; pp. 5052 - 5053 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
5/21/2009 Supplement Part 1 of 2
|
| Acceso en línea: | Ver este registro en EBSCOhost |